Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20 - F and other filings with the Securities and Exchange Commission.
01Net
-
1 ora fa
|
|
|
'TNS has a strong reputation in EMEA as a leading provider of mission - critical infrastructure and for its exchange expertise,' added Myers. 'We're expanding the breadth of options available to ...
01Net
-
5 ore fa
|
|
|
|
This performance is mainly attributed to the timely actions taken by the Company's Management regarding both securing favorable LME prices, the /$ exchange rate, as well as strict cost cotnrol. The ...
Adnkronos
-
7 ore fa
|
|
|
|
... with robust operations and tax revenue generation in Greece and an expectation to retain a listing on the Athens Exchange, where MYTILINEOS has been listed since 1995. MYTILINEOS has achieved a ...
Adnkronos
-
7 ore fa
|
|
|
... as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward - looking statements include, among others, statements concerning our future financial performance (including ...
01Net
-
8 ore fa
|
|
|
Forward - Looking Statements This release contains forward - looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 ...
01Net
-
8 ore fa
|
|
|
|
First, while building AVG Technologies, a European based cybersecurity company that our team took public on the New York Stock Exchange in 2012 and thereafter in numerous European companies we have ...
Adnkronos
-
13 ore fa
|
|
|
|
About Liftoff Liftoff is the leading growth acceleration platform for the mobile industry, helping ... including Accelerate, Direct, Influence, Monetize, Intelligence, and Vungle Exchange, support over ...
Adnkronos
-
24-4-2024
|
|
|
A small jewel based on TUC's three technological pillars, mechanical structuring, electronic management and data exchange, designed to also interface with consumer electronics thanks to the ...
01Net
-
24-4-2024
|
|
|
|
As part of the collaboration, the partners will exchange expertise, knowledge, and resources. In addition, Tetra Pharm Technologies and Glysious will conduct joint research, experiments, and tests as ...
Adnkronos
-
24-4-2024
|
|
|